An N‐acetyltransferase‐ MAPK fusion protein modulates developmental reprogramming in Physcomitrium patens
New Phytologist · 2026-07 · 251 (1) · 321-339
DOI: 10.1111/nph.71214 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Phytologist, online erschienen am 13.05.2026. Verfasst von Cloe de Luxán-Hernández und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Copenhagen, Copenhagen, 2200, Denmark. Hauptthemen laut MEDLINE: Bryopsida, Plant Proteins, Acetyltransferases, Mitogen-Activated Protein Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden, Danish Research Agency.
Abstract (Originalsprache)
We discovered a previously uncharacterized moss‐specific protein, Rosetta NATD‐MAPK 1 (RAK1) in Physcomitrium patens , which uniquely integrates MAP kinase (MAPK)‐dependent signaling with N‐acetyltransferase activity. Through phenotypical and biochemical analyses, we characterized RAK1 function in the regulation of the 2D‐to‐3D growth transition. We identified differential acetylation events associated with metabolic reprogramming in rak1 mutants and demonstrated that RAK1 has acetyltransferase activity enhanced by MAPK domain activation. Consistently, RAK1 was found to interact with proteins involved in metabolic processes. Collectively, this study uncovers a previously unknown multidomain protein and provides mechanistic insights into the interplay of post‐translational modifications during developmental reprogramming.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, University of Copenhagen, Copenhagen, 2200, Denmark.
- Department of Biomedicine, Aarhus University, Aarhus, 8000, Denmark.
- Division of Evolutionary Biology, National Institute for Basic Biology, Okazaki, 444-8585, Japan.
- Department of Biology, University of Oxford, Oxford, OX1 3EL, UK.
- Gregor Mendel Institute, Austrian Academy of Sciences, Vienna BioCenter, Vienna, 1030, Austria.
- Research Division Integrated Bioprocess Development, Institute of Chemical, Environmental and Bioscience Engineering, TU Wien, Vienna, 1060, Austria.
ORCID-Profile: Cloe de Luxán-Hernández, Thomas J Ammitsøe, Jakob V Kanne, Sabrina Stanimirovic, Rocío Redondo-Rodríguez, Milena E Roux, Liechi Zhang, Zoe Weeks, Michael Schutzbier, Gerhard Dürnberger, Elisabeth Roitinger, Oliver Spadiut, Masaki Ishikawa, Mitsuyasu Hasebe, Laura A Moody, Yasin F Dagdas, Eleazar Rodriguez, Morten Petersen
Förderung
- Novo Nordisk Fonden
- Danish Research Agency
Zitieren
APA
de Luxán-Hernández, C., Ammitsøe, T. J., Kanne, J. V., Stanimirovic, S., Redondo-Rodríguez, R., Roux, M. E., Zhang, L., Weeks, Z., Schutzbier, M., Dürnberger, G., Roitinger, E., Spadiut, O., Ishikawa, M., Hasebe, M., Moody, L. A., Dagdas, Y. F., Rodriguez, E., & Petersen, M. (2026). An N‐acetyltransferase‐ MAPK fusion protein modulates developmental reprogramming in Physcomitrium patens. New Phytologist, 251(1), 321-339. https://doi.org/10.1111/nph.71214
Vancouver
de Luxán-Hernández C, Ammitsøe TJ, Kanne JV, Stanimirovic S, Redondo-Rodríguez R, Roux ME, et al. An N‐acetyltransferase‐ MAPK fusion protein modulates developmental reprogramming in Physcomitrium patens. New Phytologist. 2026;251(1):321-339. doi:10.1111/nph.71214
BibTeX
@article{deLuxnHernndez2026,
author = {de Luxán-Hernández, Cloe and Ammitsøe, Thomas J and Kanne, Jakob V and Stanimirovic, Sabrina and Redondo-Rodríguez, Rocío and Roux, Milena E and Zhang, Liechi and Weeks, Zoe and Schutzbier, Michael and Dürnberger, Gerhard and Roitinger, Elisabeth and Spadiut, Oliver and Ishikawa, Masaki and Hasebe, Mitsuyasu and Moody, Laura A and Dagdas, Yasin F and Rodriguez, Eleazar and Petersen, Morten},
title = {An N‐acetyltransferase‐ MAPK fusion protein modulates developmental reprogramming in Physcomitrium patens},
journal = {New Phytologist},
year = {2026},
volume = {251},
number = {1},
pages = {321--339},
doi = {10.1111/nph.71214}
}
EUVIMED